CMS to Cover Hepatitis C Screening: 4 Things to Know
1. CMS concluded that HCV screening meets the U.S. Preventative Services Task Force grade B recommendations. Screening is considered reasonable and necessary for the prevention and early detection of the disease.
2. HCV screening will be covered for beneficiaries enrolled under Part A or Part B. A single screening test is covered for adults who are not defined as high risk, but who were born from 1945 through 1965.
3. The test is covered for high risk individuals. "High risk" individuals have a current or past history of illicit drug injection or have had a blood transfusion before 1992. CMS will cover annual repeat screening tests for individuals who have continued illicit drug injection after their prior negative screening.
4. CMS will cover HCV screening tests that fall in the category of FDA approved laboratory tests used with appropriate FDA approved labeling and in compliance with the Clinical Laboratory Improvement Act regulations. The test will be covered when ordered by a beneficiary's Medicare-eligible primary care physician.
More Articles on Gastroenterology:
2 Gastroenterologists on the Best GI Practice Marketing Ideas
12 Points on Endoscope Reprocessing in ASCs: Compliance, Efficiency & Choosing the Right System
The 3 Most Exciting Advances in Endoscope Reprocessing
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- 7 things ASC leaders should know for Monday — Feb. 20, 2017
- Evaluating pain management protocols in the age of new patient care models
- Are more physician-owned hospitals on the horizon? Legislation introduced to lift the ban
- Trump plans to roll out healthcare plan in March — 4 points
- 10 most common sentinel events in Q2 2016